Mark T. Esser
Impact in
- Epidemiology top 0.2%
- Cervical Cancer and HPV Research
- Respiratory viral infections research
- Hepatitis B Virus Studies
- Pneumonia and Respiratory Infections
- Virology top 2%
Papers in
- Epidemiology 59
- Respiratory viral infections research 32
- Cervical Cancer and HPV Research 24
- Pneumonia and Respiratory Infections 11
-
- SARS-CoV-2 and COVID-19 Research 10
- Viral gastroenteritis research and epidemiology 8
- Co-authors
- Eliav Barr (9 shared papers)Janine T. Bryan (7 shared papers)Tonya Villafana (15 shared papers)Filip Dubovsky (11 shared papers)Frank J. Taddeo (4 shared papers)Therese Takas (8 shared papers)Heather L. Sings (3 shared papers)M. Pamela Griffin (6 shared papers)
- Journals
- Clinical and Vaccine Immunology (9 papers)Open Forum Infectious Diseases (6 papers)PLoS ONE (5 papers)The Journal of Infectious Diseases (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Mark T. Esser
98 papers receiving 6.3k citations
Mark T. Esser's Hit Papers
Peers
Comparison fields: 5 of 120
- Epidemiology 4.5k
- Virology 334
- Infectious Diseases 1.1k
- Immunology 1.2k
- Microbiology 297
Countries citing papers authored by Mark T. Esser
This map shows the geographic impact of Mark T. Esser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Esser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Esser more than expected).
Fields of papers citing papers by Mark T. Esser
This network shows the impact of papers produced by Mark T. Esser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Esser. The network helps show where Mark T. Esser may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark T. Esser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases Hit paper breakdown → | 2007 | 1365 |
| 2 | Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants Hit paper breakdown → | 2020 | 487 |
| 3 | 2009 | 362 | |
| 4 | 2003 | 231 | |
| 5 | 2007 | 226 | |
| 6 | 2005 | 207 | |
| 7 | 2018 | 165 | |
| 8 | 2003 | 148 | |
| 9 | 2001 | 146 | |
| 10 | 2010 | 133 | |
| 11 | Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2022 | 130 |
| 12 | 2016 | 114 | |
| 13 | 2007 | 108 | |
| 14 | 2016 | 107 | |
| 15 | 2007 | 104 | |
| 16 | 2008 | 104 | |
| 17 | 2017 | 94 | |
| 18 | 2012 | 93 | |
| 19 | 2002 | 83 | |
| 20 | 1995 | 82 |
About Mark T. Esser
Mark T. Esser is a scholar working on Epidemiology, Infectious Diseases, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 101 papers that have together received 6.6k indexed citations. Recurring topics across this work include Respiratory viral infections research (32 papers), Cervical Cancer and HPV Research (24 papers), Pneumonia and Respiratory Infections (11 papers), Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (10 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Viral gastroenteritis research and epidemiology (8 papers) and Neonatal Respiratory Health Research (8 papers). The work is most often cited by research in Epidemiology (4.5k citations), Virology (334 citations), Infectious Diseases (1.1k citations), Immunology (1.2k citations) and Microbiology (297 citations). Mark T. Esser has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Eliav Barr, Janine T. Bryan, Tonya Villafana, Filip Dubovsky, Frank J. Taddeo, Therese Takas, Heather L. Sings, M. Pamela Griffin, Carlos Sattler and Cosette M. Wheeler. Their work appears in journals such as Clinical and Vaccine Immunology, Open Forum Infectious Diseases, PLoS ONE, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.